Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Sarah Cannon Research Institute research developments at ASCO 2010

Share :

2010 ASCO Annual Meeting
Published: 4 Feb 2011
Views: 7905
Rating:
Save
Dr Howard Burris, The Sarah Cannon Research Institute, Nashville
Dr Howard Burris discusses the research that Sarah Cannon Research Institute presented at ASCO 2010.

Related Videos

ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
16 Sep 2024
Trastuzumab deruxtecan effective against brain metastases in HER2-positive...
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Assessment of suicide risk in cancer patients
Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India
Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )
10 Sep 2024
Cancer journeys: Research from India
Ms. Soumita Ghose - Tata Medical Center, Kolkata
Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )
7 Sep 2024
Depression in cancer
Ms. Bidisha Samanta - Rocket Health, Kolkata, India
Depression in cancer ( Ms. Bidisha Samanta - Rocket Health, Kolkata, India )
7 Sep 2024
Managing 'fear of recurrence' of cancer patients
Ms Bincy Mathew - Manipal Hospitals, Bangalore, India
Managing 'fear of recurrence' of cancer patients ( Ms Bincy Mathew - Manipal Hospitals, Bangalore, India )
7 Sep 2024
Psychological issues in familial cancer
Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India
Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )
7 Sep 2024
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA
Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )
12 Jul 2024
Antibody drug conjugates coming to primetime and new agents for breast cancer
Dr Mariana Chavez McGregor - MD Anderson Cancer Center, Houston, USA
Antibody drug conjugates coming to primetime and new agents for breast cancer ( Dr Mariana Chavez McGregor - MD Anderson Cancer Center, Houston, USA )
12 Jul 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation